 Home > Biochemistry News > Biotechnology News > Lu Sheng launches the first prospective study of liquid biopsy for lung cancer early screening in the U.S.

Lu Sheng launches the first prospective study of liquid biopsy for lung cancer early screening in the U.S.

 Last Update: 2021-12-02
 Source: Internet
 Author: User

Tags

high tensile strength

liquid silver medicine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Palo Alto, USA, November 12, 2021/PRNewswire/ - Precision medicine company Lucence and the American veteran Palo Alto Healthcare System (VAPAHCS) cooperated in the United States Launched its first prospective and observational early cancer detection clinical study to evaluate the application value of Luxon liquid biopsy technology in lung cancer screening scenarios

This prospective, observational clinical study will compare the sensitivity and specificity of liquid biopsy combined with PET/CT and PET/CT alone in detecting lung cancer in 6-20 mm lung nodules

"Lung cancer is more common among veterans.

Lung cancer is one of the most common cancers in the world, and research has confirmed that early lung cancer screening can reduce lung cancer mortality by 20%

"Non-invasive liquid biopsy screening tests allow doctors to reduce unnecessary invasive tests, reducing costs while improving results and patient experience," said Dr.

Lusheng launched the clinical research LIQUIK in the first half of this year.

About Lusheng

Lusheng is a precision medicine company dedicated to the development and application of ultra-sensitive liquid biopsy technology to achieve early cancer detection and treatment selection guidance

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.